Skip to main content
. 2020 Jun 13;21(12):4225. doi: 10.3390/ijms21124225

Figure 5.

Figure 5

Cell-permeable NBD peptide decreased podocyte loss and basement membrane thickness in BTBR ob/ob mouse kidney. (A) Representative images of WT-1 immunohistochemistry (magnification 630×) and quantification of WT-1+ cells in glomerular cross section (gcs). Transmission electron microscopy images (magnification 9900×) and measurement of (B) glomerular basement membrane (GBM) and (C) tubular basement membrane (TBM) thickness. Data shown as scatter dot plots and mean ± SD of each group (n = 6–8 mice/group). *** p < 0.001; **** p < 0.0001 vs. diabetic vehicle control.